| scholarly article | Q13442814 |
| P50 | author | Douglas Higgs | Q5301594 |
| Ian Dunham | Q30093275 | ||
| Michelle L Holland | Q41813373 | ||
| Marco De Gobbi | Q53026545 | ||
| Karen M Lower | Q55690369 | ||
| P2093 | author name string | Jackie Sloane-Stanley | |
| Christoph Koch | |||
| David Garrick | |||
| Nicki Gray | |||
| Helena Ayyub | |||
| Michelle Rugless | |||
| Vasiliki Samara | |||
| P2860 | cites work | Translating the Histone Code | Q22065840 |
| The Polycomb group protein EZH2 directly controls DNA methylation | Q24299020 | ||
| Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity | Q24305075 | ||
| Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27 | Q24672052 | ||
| Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein | Q24682617 | ||
| Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation | Q28139187 | ||
| Control of developmental regulators by Polycomb in human embryonic stem cells | Q28235841 | ||
| A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter | Q28242432 | ||
| The relationship between chromosome structure and function at a human telomeric region | Q28304976 | ||
| The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species | Q28349324 | ||
| The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation | Q28508225 | ||
| Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains | Q28609779 | ||
| Polycomb complexes repress developmental regulators in murine embryonic stem cells | Q29547274 | ||
| Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions | Q29614512 | ||
| Partitioning and plasticity of repressive histone methylation states in mammalian chromatin | Q29614513 | ||
| Polycomb silencers control cell fate, development and cancer | Q29619697 | ||
| Annotation of cis-regulatory elements by identification, subclassification, and functional assessment of multispecies conserved sequences | Q33895983 | ||
| Identification of a conserved erythroid specific domain of histone acetylation across the alpha-globin gene cluster | Q33947031 | ||
| DNA methylation in the human γδβ-globin locus in erythroid and nonerythroid tissues | Q34251617 | ||
| EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer | Q34268216 | ||
| Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer | Q34409667 | ||
| The genomic landscape of histone modifications in human T cells | Q35094537 | ||
| Hyperconserved CpG domains underlie Polycomb-binding sites | Q35720547 | ||
| Chromatin structure and developmental expression of the human alpha-globin cluster | Q36912032 | ||
| A conserved truncated isoform of the ATR-X syndrome protein lacking the SWI/SNF-homology domain | Q40598478 | ||
| The pattern of replication at a human telomeric region (16p13.3): its relationship to chromosome structure and gene expression | Q40942805 | ||
| Understanding alpha globin gene expression: a step towards effective gene therapy. | Q41752951 | ||
| Tissue-specific TAFs counteract Polycomb to turn on terminal differentiation. | Q47070063 | ||
| How transcriptional and epigenetic programmes are played out on an individual mammalian gene cluster during lineage commitment and differentiation. | Q50940401 | ||
| Expression of alpha- and beta-globin genes occurs within different nuclear domains in haemopoietic cells. | Q52134560 | ||
| Tissue-specific histone modification and transcription factor binding in alpha globin gene expression. | Q53026451 | ||
| alpha-thalassemia resulting from a negative chromosomal position effect | Q57415425 | ||
| Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases | Q81661343 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gene silencing | Q1431332 |
| P304 | page(s) | 3889-3899 | |
| P577 | publication date | 2008-08-08 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | The role of the polycomb complex in silencing alpha-globin gene expression in nonerythroid cells | |
| P478 | volume | 112 |
| Q24622599 | A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy |
| Q28593101 | An interspecies analysis reveals a key role for unmethylated CpG dinucleotides in vertebrate Polycomb complex recruitment |
| Q37594579 | Chromosome crosstalk in three dimensions. |
| Q41270039 | DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease. |
| Q33662656 | Differential regulation of the α-globin locus by Krüppel-like Factor 3 in erythroid and non-erythroid cells |
| Q38185270 | Disruption of long-range gene regulation in human genetic disease: a kaleidoscope of general principles, diverse mechanisms and unique phenotypic consequences |
| Q38340158 | Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. |
| Q30885935 | Epigenetic signatures associated with different levels of differentiation potential in human stem cells |
| Q34027198 | Generation of bivalent chromatin domains during cell fate decisions |
| Q42076431 | H3K27me3 forms BLOCs over silent genes and intergenic regions and specifies a histone banding pattern on a mouse autosomal chromosome |
| Q27318586 | High resolution imaging reveals heterogeneity in chromatin states between cells that is not inherited through cell division |
| Q34582928 | Histone code pathway involving H3 S28 phosphorylation and K27 acetylation activates transcription and antagonizes polycomb silencing |
| Q34770424 | Molecular mechanism of yisui shengxue granule, a complex chinese medicine, on thalassemia patients suffering from hemolysis and anemia of erythrocytes |
| Q34230375 | PRC1 and PRC2 are not required for targeting of H2A.Z to developmental genes in embryonic stem cells |
| Q39029997 | PRC2-independent chromatin compaction and transcriptional repression in cancer |
| Q33740016 | Plant metabolic clusters - from genetics to genomics |
| Q35237389 | Polycomb eviction as a new distant enhancer function. |
| Q90029300 | Potential new approaches to the management of the Hb Bart's hydrops fetalis syndrome: the most severe form of α-thalassemia |
| Q39703639 | Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination |
| Q42361973 | Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia |
| Q33920071 | Sensing core histone phosphorylation - a matter of perfect timing. |
| Q38026940 | The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions. |
| Q41937379 | The molecular basis of α-thalassemia |
| Q41930765 | The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer |
| Q35351225 | Uncovering enhancer functions using the α-globin locus |
| Q38676718 | Understanding α-globin gene regulation and implications for the treatment of β-thalassemia |
| Q35836891 | α-Globin as a molecular target in the treatment of β-thalassemia |
Search more.